The Relationship between Epstein-Barr Virus Infections with Papillary Thyroid Cancer: A Review of Studies in Iran

Authors

  • Ali Daneshvar ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author
  • Ali Shafee ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author
  • Amin Ostovar Shirazi ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author
  • Maryam Lotfi ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author
  • Zahra Karbasi ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author
  • Amir Yarahmadi ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran. Author

DOI:

https://doi.org/10.61841/t4v4rs68

Keywords:

Papillary thyroid cancer, Epstein-Barr virus, EBV, PTC

Abstract

Background and aim: Papillary thyroid cancer (PTC), It is the most common thyroid cancer and one of the most common cancers of the glands. The causes of this cancer are varied but more recently, the role of viral infections has been suggested. EBV is one of the most important viruses that it is related to different types of malignancies. In this review article, The Relationship between EBV and Papillary Thyroid Cancer in studies conducted in Iran has been investigated.

Methods: This review study was performed in the period of last 10 years (2010-2020). All related articles with Keywords: EBV, EPSTEIN-BARR VIRUS, Papillary thyroid cancer, PTC, follicular thyroid cancer AND FTC searched in research engines: Google Scholar, science Direct, PubMed and Sid (for article in Persian) Entered the study. Search results showed that in this time period of 10 years, 3 related studies conducted in Iran. In this article we have summarized the results of these three studies.

Result: All three studies reviewed, emphasized that Epstein-Barr virus is associated with papillary thyroid cancer and it can be considered a risk factor for this cancer. So monitoring patients with latent EBV, for papillary thyroid cancer can be very important.

Conclusion: We found correlation between EBV and thyroid cancer in based on the current evidence. But more studies are needed to demonstrate the relationship between the virus and Papillary thyroid cancer. Future studies are warranted to reveal the significance of EBV in thyroid tumor developments.

 

Downloads

Download data is not yet available.

References

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016;66(1):7-30.

2. Glaser SL, Hsu JL, Gulley ML. Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiology and Prevention Biomarkers. 2004;13(5):688-97.

3. Joshi D, Buehring GC. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast cancer research and treatment. 2012;135(1):1-15.

4. Lawson JS, Heng B. Viruses and breast cancer. Cancers. 2010;2(2):752-72.

5. Stamatiou DP, Derdas SP, Zoras OL, Spandidos DA. Herpes and polyoma family viruses in thyroid cancer. Oncology letters. 2016;11(3):1635-44.

6. Mazzaferri E. Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment. Annual review of medicine. 1981;32(1):73-91.

7. MARTIN S, MAURICE T, VATHAIRE FD, CATHERINE H, GARDET P, TRAVAGLI J-P, et al. Long-term

results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. The Journal of Clinical Endocrinology & Metabolism. 1986;63(4):960-7.

8. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nature Reviews Cancer. 2013;13(3):184.

9. Al-Haddad S, El-Zimaity H, Hafezi-Bakhtiari S, Rajendra S, Streutker CJ, Vajpeyi R, et al. Infection and esophageal cancer. Annals of the New York Academy of Sciences. 2014;1325(1):187-96.

10. Knipe D, Howley P, Griffin D, Lamb R, Martin M, Roizman B, et al. Fields Virology, Volumes 1 and 2. 2007.

11. TAYEBI D, MOKHTARI M, SALEHI S, MOHAMMADI B, EBRAHIMPOUR M. SEROPIDEMIOLOGY OF EPSTEIN–BARR VIRUS INFECTION AMONG ASYMPTOMATIC STUDENTS OF ISLAMIC AZAD UNIVERSITY OF KAZEROON, SOUTHWEST OF IRAN. 2006.

12. Janegova A, Janega P, Rychly B, Kuracinova K, Babal P. The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases. Endokrynologia Polska. 2015;66(2):132-6.

13. Stamatiou D, Derdas SP, Symvoulakis EK, Sakorafas GH, Zoras O, Spandidos DA. Investigation of BK virus, Epstein-Barr virus and human papillomavirus sequences in postoperative thyroid gland specimens. The International journal of biological markers. 2015;30(1):104-10.

14. Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A, et al. Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. Human pathology. 2003;34(11):1170-7.

15. Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein–Barr virus persistent infection. Current opinion in virology. 2013;3(3):227-32.

16. Morrison BJ, Labo N, Miley WJ, Whitby D, editors. Serodiagnosis for tumor viruses. Seminars in oncology; 2015: Elsevier.

17. Tsai M-H, Raykova A, Klinke O, Bernhardt K, Gärtner K, Leung CS, et al. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell reports. 2013;5(2):458-70.

18. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein–Barr virus in epithelial malignancies. The Journal of pathology. 2015;235(2):323-33.

19. Callahan J, Aster J, Sklar J, Kieff E, Robertson E. Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-jkappa in human B and T cells. Leukemia. 2000;14(1):84.

20. Zimber-Strobl U, Strobl LJ, editors. EBNA2 and Notch signalling in Epstein–Barr virus mediated immortalization of B lymphocytes. Seminars in cancer biology; 2001: Elsevier.

21. Webster-Cyriaque J, Raab-Traub N. Transcription of Epstein–Barr virus latent cycle genes in oral hairy leukoplakia. Virology. 1998;248(1):53-65.

22. Banko AV, Lazarevic IB, Folic MM, Djukic VB, Cirkovic AM, Karalic DZ, et al. Characterization of the variability of Epstein-Barr virus genes in nasopharyngeal biopsies: potential predictors for carcinoma progression. PloS one. 2016;11(4):e0153498.

23. Ferretti E, Tosi E, Po A, Scipioni A, Morisi R, Espinola M, et al. Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors. The Journal of Clinical Endocrinology & Metabolism. 2008;93(10):4080-7.

24. Ghasemi M, Abedian Kenari S, Torabizadeh Z, Iri N, Marjani J, Mirabi AM. The Relationship between Epstein-Barr Virus (EBV) and Virus-Encoded BARF-1 Gene in Gastric Adenocarcinoma. Journal of Mazandaran University of Medical Sciences. 2011;21(82):10-6.

25. Mr H, A. R, F. Z, F N. Frequency of Epstein Barr Virus in esophageal squamous cell carcinoma biopsies in Mazandaran and Golestan provinces in 2008. Iranian Journal of Medical Microbiology. 2009;3(1):43-.

26. Akbari A, Razzaghi Z, Homaee F, Khayamzadeh M, Movahedi M, Akbari ME. Parity and breastfeeding are preventive measures against breast cancer in Iranian women. Breast cancer. 2011;18(1):51-5.

27. Hejazi H, Hejazi H. Study on the association of Epstein-Barr virus with breast cancer in Khorramabad breast cancer patients, Iran. Yafteh. 2019;21(1).

28. SALAHSHOURNIA Z, HEJAZI H, HADI F, SAEEDI Z. THE STUDY OF RELATIONSHIP BETWEEN EPSTEIN-BARR VIRUS AND BREAST CANCER IN ISFAHAN PROVINCE. 2018.

29. Mozafari L, Najafipour S, Meshkibaf MH, Moravej A. Expression of Epstein-Barr virus in Hodgkin lymphoma Specimens in IRAN. Journal of Fasa University of Medical Sciences. 2013;3(2):143-8.

30. MOZAFARI L, NAJAFIPOUR S, MESHKIBAF MH, MORAVEJ A. Analysis of the presence of Epstein-Barr virus in Hodgkin's lymphoma in Iranian children by EBER in situ hybridization. 2014.

31. SAR N. Detection of Epstein-Barr virus infection in lymphoma: ELISA and PCR method. Tehran University Medical Journal TUMS Publications. 2010;67(11):787-92.

32. Homayouni M, Arabzadeh SAM, Nili F, Razi F, Amoli MM. Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma. Pathology-Research and Practice. 2017;213(7):854-6.

33. Moghoofei M, Mostafaei S, Nesaei A, Etemadi A, Sadri Nahand J, Mirzaei H, et al. Epstein–Barr virus and thyroid cancer: The role of viral expressed proteins. Journal of cellular physiology. 2019;234(4):3790-9.

34. Mokhtari M, Bahreini M, Isfahani, Naji F, Safaei A. Expression of Epstein-Barr Virus Nuclear Antigen (EBNA) in Papillary Thyroid Carcinoma in a Population of Patients in Isfahan City, Iran. Journal Of Isfahan Medical School. 2017;34(415):1648-52.

35. Bychkov A, Keelawat S. Epstein–Barr virus and thyroid cancer: the controversy remains. Journal of endocrinological investigation. 2017;40(8):891-2.

36. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. Journal of medical virology. 2005;75(2):276-81.

37. Chang ET, Adami H-O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology and Prevention Biomarkers. 2006;15(10):1765-77.

38. Cao S-M, Liu Z, Jia W-H, Huang Q-H, Liu Q, Guo X, et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PloS one. 2011;6(4):e19100.

39. Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. International journal of cancer. 2012;131(2):406-16.

40. Richman DD, Whitley RJ, Hayden FG. Clinical virology: John Wiley & Sons; 2016.

Downloads

Published

20.07.2026

Issue

Vol. 24 No. 8 (2020): 24 (8) 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Daneshvar, A., Shafee, A., Shirazi, A. O., Lotfi, M., Karbasi, Z., & Yarahmadi, A. (2026). The Relationship between Epstein-Barr Virus Infections with Papillary Thyroid Cancer: A Review of Studies in Iran. International Journal of Psychosocial Rehabilitation, 24(8), 8413-8420. https://doi.org/10.61841/t4v4rs68